Medication info
Alvix Tablet (Memantine Hydrochloride)

Alvix Tablet (Memantine Hydrochloride)

Prescription medicationTabletOral
Ingredient · strength
Memantine Hydrochloride›10mg / 1 tablet
Manufacturer / importer
Korea Pharma Co., Ltd.
Appearance
White elongated film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 200501552 · Notified 2005.03.24 · Insurance code 653001550

Summary

Main use
Treatment of moderate to severe Alzheimer's disease
Who takes it
Adults
Adult dose
This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1-7) Administer 5mg once daily for 7 days. Week 2 (days 8-14) Administer 10mg once daily for 7 days. Week 3 (days 15-21) Administer 15mg once daily for 7 days. From week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose-escalation method after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As data on the use of memantine in patients with severe hepatic impairment are unavailable, it is preferable not to administer this medicine.

Ingredients

Manufacturer
Korea Pharma Co., Ltd.

Efficacy & effects

Treatment of moderate to severe Alzheimer's disease

  • Alzheimer's disease
View approved original text

This medication is used to alleviate the symptoms of Alzheimer's disease classified as moderate to severe and to improve the patient's cognitive function.

How to take

Adult dose

This medicine is administered orally once daily, at the same time each day. If necessary, it may be administered twice daily. This medicine may be taken with or without food. 1. Adults Dose escalation: The maximum daily dose is 20mg. To minimize the risk of adverse reactions, increase the dose by 5mg per week over the first 3 weeks as follows to reach the maintenance dose. Week 1 (days 1-7) Administer 5mg once daily for 7 days. Week 2 (days 8-14) Administer 10mg once daily for 7 days. Week 3 (days 15-21) Administer 15mg once daily for 7 days. From week 4 onward Administer 20mg once daily. Maintenance dose: The recommended maintenance dose is 20mg once daily. 2. Elderly: Based on clinical data, the recommended dose for elderly patients aged 65 years and older is 20mg once daily. 3. Patients with renal impairment: No dose adjustment is necessary in patients with mild renal impairment (creatinine clearance: 50-80 mL/min). In patients with moderate renal impairment (creatinine clearance 30-49 mL/min), reduce the daily dose to 10mg. If well tolerated, the dose may be increased to 20mg daily according to the standard dose-escalation method after at least 7 days of treatment. In patients with severe renal impairment (creatinine clearance 5-29 mL/min), reduce the daily dose to 10mg. 4. Patients with hepatic impairment: No dose adjustment is necessary in patients with mild or moderate hepatic impairment (Child-Pugh A, Child-Pugh B). As data on the use of memantine in patients with severe hepatic impairment are unavailable, it is preferable not to administer this medicine.

Precautions

This medication should not be used in patients with hypersensitivity to its components or severe impairment of liver and kidney function. Caution is especially needed for patients with epilepsy or a history of seizures, as well as those taking certain NMDA antagonists. Patients with conditions that may increase urinary pH or with recent cardiac conditions should also be administered with care. While taking this medication, symptoms such as dizziness, headache, constipation, drowsiness, and hypertension may occur, so careful monitoring of the patient's condition is necessary. There may be interactions with other medications, so especially when taking antipsychotic drugs, muscle relaxants, anticoagulants, etc., it is advised to consult a physician or pharmacist. Women who are pregnant or may become pregnant should carefully consider the risks and benefits before taking this medication, and it is recommended to discontinue breastfeeding if nursing. This medication should not be used in children or adolescents under 18 years of age, as safety and efficacy have not been established. In case of overdose, central nervous system symptoms or gastrointestinal symptoms may occur, and medical attention should be sought promptly. This medication may slow down the patient's response speed, so caution is especially necessary when driving or operating machinery. When storing, keep it out of reach of children and do not transfer it to a different container.

Side effects

  • Dizziness
  • headache
  • constipation
  • drowsiness
  • hypertension
  • fungal infection
  • drug allergy reaction
  • drowsiness
  • confusion
  • hallucination
Show 33 more
  • psychiatric reactions
  • dizziness
  • balance disorder
  • gait abnormalities
  • seizures
  • heart failure
  • hypertension
  • venous thromboembolism
  • thromboembolism
  • dyspnea
  • constipation
  • vomiting
  • pancreatitis
  • elevated liver function test results
  • hepatitis
  • headache
  • fatigue
  • feeling of tiredness
  • weakness
  • diarrhea
  • confusion
  • drowsiness
  • anxiety
  • aggression
  • hallucination
  • gait disorder
  • restlessness
  • psychosis
  • visual hallucination
  • convulsions
  • drowsiness
  • stupor
  • unconsciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to prevent air and moisture from entering, and it is safe to store it at room temperature between 1°C and 30°C. Storing it this way will help maintain the medication's effectiveness for a longer period.

Appearance and packaging

Appearance

White elongated film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.